Colfax traded at $40.39 this Monday April 4th, decreasing $0.20 or 0.49 percent since the previous trading session. Looking back, over the last four weeks, Colfax lost 0.12 percent. Over the last 12 months, its price fell by 9.78 percent. Looking ahead, we forecast Colfax to be priced at 39.27 by the end of this quarter and at 36.10 in one year, according to Trading Economics global macro models projections and analysts expectations.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Colfax Corporation is a technology company. The Company provides orthopedic care and fabrication technology products and services. It operates through two segments: Fabrication Technology and Medical Technology. Fabrication Technology segment is a supplier of welding equipment, cutting equipment, automated welding and cutting systems, and consumables. Medical Technology segment is a provider of orthopedic solutions, providing orthopedic devices, software and services. Its fabrication technology products are marketed under the ESAB brand. ESAB's range of cutting and welding consumables includes electrodes, cored and solid wire and fluxes. The Company, through its subsidiary DJO Global, Inc. (DJO), provides medical devices that provide solutions for musculoskeletal health, vascular health and pain management. It also provides devices for fracture fixation, joint fusion and soft tissue injury repair. Its brands include Aircast, Chattanooga, Regeneration, COMPEX, DJO Surgical and PROCARE.